Genetic abnormalities associated with high-risk stage 4 NB include hemizygous deletions of the q arm of chromosome 11 (up to 62.5% of tumors) and of the p arm of chromosome 1 (25–35% of tumors), and MYCN amplification in ~25% of tumors3,4,7–12. This evidence concerns the gene MYCN and neuroblastoma.